Logo

1 of 3
FILE - In this Monday, March 16, 2020 file photo, a patient receives a shot in the first-stage study of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. On Friday, March 20, 2020, The Associated Press reported on stories circulating online incorrectly asserting that the first person to receive the experimental vaccine is a crisis actor. All participants who volunteered for the test were screened and had to meet a set list of criteria. They were not hired as actors to simulate a role. (AP Photo/Ted S. Warren)
AP/Ted S. Warren
A researcher works on a vaccin against the new coronavirus COVID-19 at the Copenhagen's University research lab in Copenhagen, Denmark, on March 23, 2020. - At Copenhagen university, a team of about 10 researchers is working around the clock to develop a vaccine against Covid-19 that could apply for clinical trial before within nine months. The vaccine will be based on two components : the protein which is on the surface of the coronavirus, called the spike protein that researchers express in the lab and then attach it on the surface of a virus-like particle. (Photo by Thibault Savary / AFP) (Photo by THIBAULT SAVARY/AFP via Getty Images)
THIBAULT SAVARY/AFP via Getty Im
Advertisement

The coronavirus isn’t mutating very quickly as it spreads — which means a vaccine could potentially provide years of protection, according to a report.

Peter Thielen, a molecular biologist with Johns Hopkins University Applied Physics Laboratory, told the Washington Post. that the strains currently in US only have seen around four to 10 genetic variations since the outbreak in Wuhan, China,

“That’s a relatively small number of mutations for having passed through a large number of people,” Thielen said. “At this point the mutation rate of the virus would suggest that the vaccine developed for SARS-CoV-2 would be a single vaccine, rather than a new vaccine every year like the flu vaccine.”

Stanley Perlman, a virologist at the University of Iowa, agreed that the virus appears to be fairly stable compared to other illnesses.

“The virus has not mutated to any significant extent,” Perlman told the newspaper.

But other experts said that that only time will tell whether the virus will require a one-time shot for protection, which is the case with the measles.

“Just one ‘pretty bad’ strain for everybody so far. If it’s still around in a year, by that point we might have some diversity,” Benjamin Neuman, a virologist with Texas A&M University at Texarkana, told the Washington Post.

The coronavirus had infected more than 436,000 people across the world as of Wednesday, causing around 20,000 deaths, according to the latest figures from the John Hopkins University.

Comments
anonymous profile image
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy